Panel Discussion: Business Development Perspectives on the Oligonucleotides Space

Time: 2:30 pm
day: Day Two


  • Exploring historical trends in business development and financing for oligonucleotide therapeutics
  • Uncovering the challenges and opportunities these trends present for those attempting to innovate within this disease area
  • Explaining what investors need to see in order to invest
  • Perspectives on the need to demonstrate both mechanistic understanding and a regulatory pathway through to the market